JaLCDOI 10.18926/AMO/68362
FullText URL 79_1_051.pdf
Author Miura, Taro| Kawasaki, Yoichi| Hamano, Hirofumi| Zamami, Yoshito| Sendo, Toshiaki|
Abstract Photoinitiators are used in the manufacture of many daily products, and may produce harmful effects due to their cytotoxicity. They have also been detected in human serum. Here, we investigated the histamine-producing effects in HMC-1 cells and the inflammatory cytokine release effects in RAW264 cells for four photoinitiators: 1-hydroxycyclohexyl phenyl ketone; 2-isopropylthioxanthone; methyl 2-benzoylbenzoate; and 2-methyl-4´-(methylthio)-2-morpholinopropiophenone. All four promoted histamine production in HMC-1 cells; however, they did not significantly affect the release of inflammatory cytokines in RAW264 cells. These findings suggest that these four photoinitiators induce inflammatory cytokine-independent histamine production, potentially contributing to histamine-mediated chronic inflammation in vitro.
Keywords photoinitiator ink injection histamine inflammation
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2025-02
Volume volume79
Issue issue1
Publisher Okayama University Medical School
Start Page 51
End Page 58
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2025 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 40012160
Web of Science KeyUT 001440463800007
FullText URL fulltext.pdf
Author Okawa, Yasumasa| Ushio, Soichiro| Izushi, Yasuhisa| Kitamura, Yoshihisa| Zamami, Yoshito| Sendo, Toshiaki|
Keywords anxiolytic chotosan inflammation serotonin receptor Uncaria hook
Published Date 2024-09-04
Publication Title Frontiers in Pharmacology
Volume volume15
Publisher Frontiers Media
Start Page 1471602
ISSN 1663-9812
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2024 Okawa, Ushio, Izushi, Kitamura, Zamami and Sendo.
File Version publisher
PubMed ID 39295939
DOI 10.3389/fphar.2024.1471602
Web of Science KeyUT 001315388700001
Related Url isVersionOf https://doi.org/10.3389/fphar.2024.1471602
JaLCDOI 10.18926/AMO/67197
FullText URL 78_3_227.pdf
Author Wada, Yudai| Ushio, Soichiro| Kitamura, Yoshihisa| Zamami, Yoshito| Sendo, Toshiaki|
Abstract Zolpidem, a non-benzodiazepine hypnotic, is primarily used to treat insomnia. In a previous study, pior treatment with non-benzodiazepine receptor agonists was associated with inflammation. The present study aimed to clarify the association between the effects of zolpidem and inflammation in mice treated with lipopolysaccharide (LPS), a known model of inflammation. We assessed the zolpidem-induced loss of righting reflex (LORR) duration 24 h after LPS treatment in mice. Additionally, the expressions of γ-aminobutyric acid (GABA)A receptor subunit and K+-Cl− cotransporter isoform 2 (KCC2) mRNA in the hippocampus and frontal cortex were examined in LPS-treated mice. Pretreatment with LPS was associated with significantly prolonged duration of zolpidem-induced LORR compared to control mice. This effect was significantly attenuated by administering bicuculline, a GABAA receptor antagonist, or flumazenil, a benzodiazepine receptor antagonist, in LPS-treated mice. Compared to controls, LPS-treated mice showed no significant change in the expression of GABAA receptor subunits in the hippocampus or frontal cortex. Bumetanide, an Na+-K+-2Cl− cotransporter isoform 1 blocker, attenuated the extended duration of zolpidem-induced LORR observed in LPS-treated mice. LPS significantly decreased Kcc2 mRNA expression in the hippocampus and the frontal cortex. These findings suggest that inflammation increases zolpidem-induced LORR, possibly through a reduction in KCC2 expression.
Keywords lipopolysaccharide zolpidem GABAA receptor K+-Cl− cotransporters
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2024-06
Volume volume78
Issue issue3
Publisher Okayama University Medical School
Start Page 227
End Page 235
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2024 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 38902210
Web of Science KeyUT 001267351000003
FullText URL fulltext.pdf
Author Ushio, Soichiro| Wada, Yudai| Nakamura, Mizuki| Matsumoto, Daiki| Hoshika, Kota| Shiromizu, Shoya| Iwata, Naohiro| Esumi, Satoru| Kajizono, Makoto| Kitamura, Yoshihisa| Sendo, Toshiaki|
Keywords anxiolytic inflammation immunomodulation macrophages Kampo medicine
Published Date 2022-08-12
Publication Title Frontiers In Pharmacology
Volume volume13
Publisher Frontiers Media S.A.
Start Page 890048
ISSN 1663-9812
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2022 Ushio, Wada, Nakamura, Matsumoto, Hoshika, Shiromizu, Iwata, Esumi, Kajizono, Kitamura and Sendo.
File Version publisher
PubMed ID 36034871
DOI 10.3389/fphar.2022.890048
Web of Science KeyUT 000860773600001
Related Url isVersionOf https://doi.org/10.3389/fphar.2022.890048
JaLCDOI 10.18926/AMO/63410
FullText URL 76_2_167.pdf
Author Higashionna, Tsukasa| Ushio, Soichiro| Esumi, Satoru| Murakawa, Kiminaka| Kitamura, Yoshihisa| Sendo, Toshiaki|
Abstract Febrile neutropenia (FN) is a serious side effect in patients undergoing cancer chemotherapy and frequently proves fatal. Since infection control is crucial in the management of FN, the antimicrobial agent cefozopran (CZOP) has been recommended but not approved for routine use in clinical care of FN in Japan. However, few studies of CZOP in the management of FN have used a thrice daily dose schedule. The aim of this study was to retrospectively compare the efficacy and safety of CZOP at a dose of 1 g three times daily to those of cefepime (CFPM) in the treatment of FN in our lung cancer patients. The response rates of the CZOP and CFPM groups were 89.5% (17/19 cases) and 83.0% (39/47 cases), respectively, with no significant difference between the two groups. The median duration of antimicrobial treatment was 6 days (4-10 days) in the CZOP group and 7 days (3-13 days) in the CFPM group, with no significant difference between groups. The incidence rates of adverse events were 21.1% (4/19 cases) in the CZOP group and 19.1% (9/47 cases) in the CFPM group. No adverse events of Grade 3 or higher were observed in either group. The findings of the present study suggest that CZOP administration at a dose of 1 g three times per day as an antimicrobial treatment alternative against FN.
Keywords febrile neutropenia cefozopran cefepime lung cancer retrospective
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2022-04
Volume volume76
Issue issue2
Publisher Okayama University Medical School
Start Page 167
End Page 172
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2022 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 35503444
Web of Science KeyUT 000792374900008
Title Alternative Drug interaction (50. Drug interaction mediated transporters)
FullText URL 133_68.pdf
Author Manabe, Yohei| Esumi, Satoru| Sendo, Toshiaki|
Publication Title Journal of Okayama Medical Association
Published Date 2021-04-01
Volume volume133
Issue issue1
Start Page 68
End Page 72
ISSN 0030-1558
Related Url isVersionOf https://doi.org/10.4044/joma.133.68
language Japanese
Copyright Holders Copyright (c) 2021 岡山医学会
File Version publisher
DOI 10.4044/joma.133.68
NAID 130008034821
Title Alternative Epidemiological characteristics of novel coronavirus infection in Okayama Prefecture
FullText URL 133_43.pdf
Author Higashionna, Tsukasa| Sendo, Toshiaki| Kusano, Nobuchika| Tsukahara, Hirokazu|
Keywords 疫学的調査 (epidemiological characteristics) 岡山 (Okayama Prefecture) 新型コロナウイルス感染症 (COVID-19) PCR検査 (PCR testing) SARS-CoV-2
Publication Title Journal of Okayama Medical Association
Published Date 2021-04-01
Volume volume133
Issue issue1
Start Page 43
End Page 48
ISSN 0030-1558
Related Url isVersionOf https://doi.org/10.4044/joma.133.43
language Japanese
Copyright Holders Copyright (c) 2021 岡山医学会
File Version publisher
DOI 10.4044/joma.133.43
NAID 130008034824
Title Alternative Investigation of neural mechanisms involved in pleasant and unpleasant emotions or motivation using behavioral pharmacological techniques
FullText URL 133_23.pdf
Author Sendo, Toshiaki|
Keywords 脳内自己刺激行動 ドパミン 意欲 動機づけ 変異PC12細胞
Publication Title Journal of Okayama Medical Association
Published Date 2021-04-01
Volume volume133
Issue issue1
Start Page 23
End Page 29
ISSN 0030-1558
Related Url isVersionOf https://doi.org/10.4044/joma.133.23
language Japanese
Copyright Holders Copyright (c) 2021 岡山医学会
File Version publisher
DOI 10.4044/joma.133.23
NAID 130008034814
Title Alternative Drug interaction (49. Interaction of novel oral molecular target drugs)
FullText URL 132_174.pdf
Author Kinashi, Yu| Esumi, Satoru| Sendo, Toshiaki|
Publication Title Journal of Okayama Medical Association
Published Date 2020-12-01
Volume volume132
Issue issue3
Start Page 174
End Page 179
ISSN 0030-1558
Related Url isVersionOf https://doi.org/10.4044/joma.132.174
language Japanese
Copyright Holders Copyright (c) 2020 岡山医学会
File Version publisher
DOI 10.4044/joma.132.174
NAID 130007950564
FullText URL fulltext.pdf
Author Asanuma, Masato| Okumura-Torigoe, Nao| Miyazaki, Ikuko| Murakami, Shinki| Kitamura, Yoshihisa| Sendo, Toshiaki|
Keywords astrocyte neuroprotection region-specificity striatum mesencephalon oxidative stress 6-hydroxydopamine Nrf2 phase II detoxifying molecules
Published Date 2019-01-30
Publication Title International Journal of Molecular Sciences
Volume volume20
Issue issue3
Publisher MDPI
Start Page 598
ISSN 1422-0067
NCID AA12038549
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
File Version publisher
PubMed ID 30704073
DOI 10.3390/ijms20030598
Web of Science KeyUT 000462412500142
Related Url isVersionOf https://doi.org/10.3390/ijms20030598
FullText URL fulltext.pdf
Author Kikuoka, Ryo| Miyazaki, Ikuko| Kubota, Natsuki| Maeda, Megumi| Kagawa, Daiki| Moriyama, Masaaki| Sato, Asuka| Murakami, Shinki| Kitamura, Yoshihisa| Sendo, Toshiaki| Asanuma, Masato|
Published Date 2020-11-26
Publication Title Scientific Reports
Volume volume10
Issue issue1
Publisher Nature Research
Start Page 20698
ISSN 2045-2322
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s) 2020
File Version publisher
PubMed ID 33244123
DOI 10.1038/s41598-020-77652-4
Web of Science KeyUT 000596329600054
Related Url isVersionOf https://doi.org/10.1038/s41598-020-77652-4
JaLCDOI 10.18926/AMO/61215
FullText URL 74_6_545.pdf
Author Tatebe, Yasuhisa| Kanamitsu, Kiichiro| Kanzaki, Hirotaka| Ishida, Hisashi| Fujiwara, Kaori| Washio, Kana| Kitamura, Yoshihisa| Sendo, Toshiaki| Shimada, Akira| Tsukahara, Hirokazu|
Abstract Polymorphisms in methotrexate transporter pathways have been associated with methotrexate toxicities and clearance. Recent genome-wide association studies have revealed that the SLCO1B1 T521C variant is associated with methotrexate elimination. We present a case of a pediatric patient with acute lymphoblastic leukemia who suffered from persistently high plasma methotrexate concentrations and acute kidney injuries after the admin-istration of a medium dose of methotrexate. Subsequent genetic analysis showed that he was a carrier of dys-functional genetic variants associated with methotrexate clearance. This case highlights that polymorphisms of methotrexate transporter pathways can adversely affect methotrexate elimination in a clinically significant manner.
Keywords methotrexate polymorphism drug elimination acute kidney injury acute lymphoblastic leukemia
Amo Type Case Report
Publication Title Acta Medica Okayama
Published Date 2020-12
Volume volume74
Issue issue6
Publisher Okayama University Medical School
Start Page 545
End Page 550
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2020 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 33361876
Web of Science KeyUT 000601203600012
NAID 120006948942
Title Alternative Drug interaction (48. Interaction of drug with extracorporeal membrane oxygenation (ECMO))
FullText URL 132_102.pdf
Author Okawa, Yasumasa| Esumi, Satoru| Sendo, Toshiaki|
Publication Title Journal of Okayama Medical Association
Published Date 2020-08-03
Volume volume132
Issue issue2
Start Page 102
End Page 107
ISSN 0030-1558
Related Url isVersionOf https://doi.org/10.4044/joma.132.102
language Japanese
Copyright Holders Copyright (c) 2020 岡山医学会
File Version publisher
DOI 10.4044/joma.132.102
NAID 130007895002
JaLCDOI 10.18926/AMO/60368
FullText URL 74_4_301.pdf
Author Takahashi, Kei| Kitamura, Yoshihisa| Ushio, Soichiro| Sendo, Toshiaki|
Abstract Ketamine has been clinically proven to ameliorate depression, including treatment-resistant depression. The detailed mechanism of action of ketamine in treatment-resistant depression remains unclear. We examined the effects of ketamine on the immobility times of adrenocorticotropic hormone (ACTH)-treated rats during the forced swim test, and we explored the mechanism by which ketamine acts in this model. We investigated the neuroanatomical site of action by microinjecting ketamine into the medial prefrontal cortex of rats. A significant reduction of the rats’ immobility during the forced swim test was observed after the intraperitoneal injection of ketamine in both saline- and ACTH-treated rats. The microinjection of ketamine into the medial prefrontal cortex also decreased immobility during the forced swim test in both saline- and ACTH-treated rats. The immobility-decreasing effect of intraperitoneally injected ketamine was blocked by administering WAY100635, a 5-HT1A receptor antagonist, into the medial prefrontal cortex. These findings contribute to the evidence that ketamine can be useful against treatment-resistant depressive conditions. The immobility-reducing effects of ketamine might be mediated by 5-HT1A receptor activity in the medial prefrontal cortex.
Keywords ketamine adrenocorticotropic hormone forced swim test medial prefrontal cortex 5-HT1A receptor
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2020-08
Volume volume74
Issue issue4
Publisher Okayama University Medical School
Start Page 301
End Page 306
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2020 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 32843761
Web of Science KeyUT 000562508700005
NAID 120006880207
FullText URL fulltext.pdf
Author Masaoka, Yasuyuki| Kawasaki, Yoichi| Kikuoka, Ryo| Ogawa, Atsushi| Esumi, Satoru| Wada, Yudai| Ushio, Soichiro| Kitamura, Yoshihisa| Sendo, Toshiaki|
Keywords Valganciclovir Simple suspension method Stability HPLC Gavage tube
Published Date 2020-07-07
Publication Title Journal of Pharmaceutical Health Care and Sciences
Volume volume6
Issue issue1
Publisher BMC
Start Page 16
ISSN 2055-0294
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s). 2020
File Version publisher
PubMed ID 32655872
DOI 10.1186/s40780-020-00172-w
Web of Science KeyUT 000549139200001
Related Url isVersionOf https://doi.org/10.1186/s40780-020-00172-w
Title Alternative Drug interaction (47. Combination with general anesthetics)
FullText URL 132_29.pdf
Author Igawa, Yusuke| Esumi, Satoru| Kitamura, Yoshihisa| Sendo, Toshiaki|
Publication Title Journal of Okayama Medical Association
Published Date 2020-04-01
Volume volume132
Issue issue1
Start Page 29
End Page 33
ISSN 0030-1558
Related Url isVersionOf https://doi.org/10.4044/joma.132.29
language Japanese
Copyright Holders Copyright (c) 2020 岡山医学会
File Version publisher
DOI 10.4044/joma.132.29
NAID 130007840319
FullText URL fulltext.pdf
Author Takeda, Tatsuaki| Yamamoto, Hiromasa| Suzawa, Ken| Tomida, Shuta| Miyauchi, Shunsaku| Araki, Kota| Nakata, Kentaro| Miura, Akihiro| Namba, Kei| Shien, Kazuhiko| Soh, Junichi| Shien, Tadahiko| Kitamura, Yoshihisa| Sendo, Toshiaki| Toyooka, Shinichi|
Keywords breast cancer drug resistance lung cancer neratinib YES1
Published Date 2019-12-19
Publication Title Cancer Science
Volume volume111
Issue issue3
Publisher Wiley
Start Page 849
End Page 856
ISSN 1347-9032
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2019 The Authors.
File Version publisher
PubMed ID 31856375
DOI 10.1111/cas.14289
Web of Science KeyUT 000507433400001
Related Url isVersionOf https://doi.org/10.1111/cas.14289
Title Alternative Drug interaction(46. Blending change and interaction of an injection drug)
FullText URL 131_161.pdf
Author Morishita, Yosuke| Esumi, Satoru| Nishihara, Shigeki| Kitamura, Yoshihisa| Sendo, Toshiaki|
Publication Title Journal of Okayama Medical Association
Published Date 2019-12-02
Volume volume131
Issue issue3
Start Page 161
End Page 164
ISSN 0030-1558
Related Url isVersionOf https://doi.org/10.4044/joma.131.161
language Japanese
Copyright Holders Copyright (c) 2019 岡山医学会
File Version publisher
DOI 10.4044/joma.131.161
NAID 130007782628
FullText URL fulltext.pdf
Author Hagiya, Hideharu| Koyama, Toshihiro| Zamami, Yoshito| Tatebe, Yasuhisa| Funahashi, Tomoko| Shinomiya, Kazuaki| Kitamura, Yoshihisa| Hinotsu, Shiro| Sendo, Toshiaki| Rakugi, Hiromi| Kano, Mitsunobu R.|
Keywords adult intensive & critical care epidemiology geriatric medicine health & safety health policy public health
Published Date 2019-12-11
Publication Title BMJ OPEN
Volume volume9
Issue issue12
Publisher BMJ Publishing Group
Start Page e033462
ISSN 2044-6055
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © Author(s) (or theiremployer(s)) 2019.
File Version publisher
PubMed ID 31831549
DOI 10.1136/bmjopen-2019-033462
Web of Science KeyUT 000512773400250
Related Url isVersionOf https://doi.org/10.1136/bmjopen-2019-033462
FullText URL fulltext.pdf
Author Koyama, Toshihiro| Sasaki, Misato| Hagiya, Hideharu| Zamami, Yoshito| Funahashi, Tomoko| Ohshima, Ayako| Tatebe, Yasuhisa| Mikami, Naoko| Shinomiya, Kazuaki| Kitamura, Yoshihisa| Sendo, Toshiaki| Hinotsu, Shiro| Kano, Mitsunobu R.|
Published Date 2019-12-27
Publication Title Scientific Reports
Volume volume9
Publisher Nature Publishing Group
Start Page 20235
ISSN 2045-2322
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s) 2019
File Version publisher
PubMed ID 31882673
DOI 10.1038/s41598-019-56388-w
Web of Science KeyUT 000509351200002
Related Url isVersionOf https://doi.org/10.1038/s41598-019-56388-w